| 2.7 |
13.4 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 2.2 |
6.7 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 2.1 |
8.5 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 1.8 |
5.5 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 1.8 |
7.2 |
GO:0046878 |
positive regulation of saliva secretion(GO:0046878) |
| 1.7 |
5.1 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 1.7 |
1.7 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 1.6 |
9.8 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 1.6 |
4.9 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 1.6 |
6.5 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 1.6 |
8.1 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 1.6 |
11.1 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 1.6 |
7.8 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 1.5 |
1.5 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 1.5 |
4.4 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.3 |
5.4 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 1.3 |
5.3 |
GO:0045608 |
inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 1.3 |
3.8 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 1.1 |
3.4 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 1.1 |
6.7 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.1 |
7.7 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 1.1 |
12.8 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 1.1 |
32.6 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 1.0 |
5.2 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 1.0 |
3.1 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 1.0 |
9.3 |
GO:0031424 |
keratinization(GO:0031424) |
| 1.0 |
8.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 1.0 |
2.0 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 1.0 |
6.0 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 1.0 |
3.0 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 1.0 |
4.9 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 1.0 |
4.9 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.9 |
1.9 |
GO:0060760 |
positive regulation of cytokine-mediated signaling pathway(GO:0001961) regulation of type I interferon-mediated signaling pathway(GO:0060338) positive regulation of type I interferon-mediated signaling pathway(GO:0060340) positive regulation of response to cytokine stimulus(GO:0060760) |
| 0.9 |
2.8 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.9 |
2.8 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.9 |
2.8 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.9 |
2.7 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.9 |
3.6 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.9 |
0.9 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.9 |
0.9 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.9 |
4.5 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.9 |
11.7 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.9 |
0.9 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.9 |
4.4 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.9 |
3.5 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.9 |
2.6 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.9 |
3.5 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.9 |
4.3 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.9 |
3.5 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.9 |
2.6 |
GO:1905065 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.9 |
1.7 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.9 |
0.9 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.9 |
3.4 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.8 |
2.5 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.8 |
2.5 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.8 |
2.4 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.8 |
1.6 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.8 |
3.3 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.8 |
3.2 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.8 |
13.7 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.8 |
3.2 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.8 |
1.6 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.8 |
2.4 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.8 |
4.0 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.8 |
4.7 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.8 |
2.3 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.8 |
5.3 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.8 |
16.7 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.8 |
0.8 |
GO:0045445 |
myoblast differentiation(GO:0045445) |
| 0.8 |
2.3 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.8 |
5.3 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.8 |
1.5 |
GO:0071824 |
protein-DNA complex subunit organization(GO:0071824) |
| 0.8 |
2.3 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.7 |
3.0 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.7 |
0.7 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.7 |
1.5 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.7 |
1.5 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.7 |
2.2 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.7 |
0.7 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.7 |
4.3 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.7 |
0.7 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.7 |
2.1 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.7 |
0.7 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.7 |
2.1 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.7 |
1.4 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.7 |
2.8 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.7 |
8.2 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.7 |
4.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.7 |
0.7 |
GO:0014831 |
gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 0.7 |
2.0 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.7 |
2.0 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.7 |
2.0 |
GO:2000562 |
positive regulation of defense response to bacterium(GO:1900426) negative regulation of interferon-gamma secretion(GO:1902714) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.7 |
4.0 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.7 |
4.7 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.7 |
2.7 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.7 |
2.7 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.7 |
2.6 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.6 |
2.5 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.6 |
2.5 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
| 0.6 |
0.6 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.6 |
1.2 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.6 |
1.9 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.6 |
1.9 |
GO:1902308 |
regulation of peptidyl-serine dephosphorylation(GO:1902308) |
| 0.6 |
2.5 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.6 |
2.5 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.6 |
7.3 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.6 |
2.4 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.6 |
1.2 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.6 |
3.6 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.6 |
3.0 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.6 |
1.8 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.6 |
5.9 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.6 |
2.9 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.6 |
1.8 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 |
1.8 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.6 |
4.6 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
| 0.6 |
2.3 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.6 |
0.6 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.6 |
1.7 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.6 |
2.8 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.6 |
2.8 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.6 |
1.7 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.6 |
1.7 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.5 |
1.1 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.5 |
3.8 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.5 |
6.0 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.5 |
6.5 |
GO:0022615 |
protein to membrane docking(GO:0022615) |
| 0.5 |
1.6 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.5 |
7.6 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.5 |
3.2 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.5 |
2.7 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.5 |
2.1 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.5 |
2.1 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.5 |
1.6 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.5 |
2.1 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.5 |
5.7 |
GO:0033129 |
positive regulation of histone phosphorylation(GO:0033129) |
| 0.5 |
0.5 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.5 |
2.0 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.5 |
1.5 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.5 |
2.5 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.5 |
3.6 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.5 |
2.0 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.5 |
2.0 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.5 |
2.0 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.5 |
1.5 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.5 |
1.5 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.5 |
1.5 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.5 |
1.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.5 |
2.5 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.5 |
2.0 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.5 |
6.0 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.5 |
1.5 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.5 |
1.5 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.5 |
1.5 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.5 |
2.4 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.5 |
3.4 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.5 |
2.9 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.5 |
1.0 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.5 |
5.2 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.5 |
0.9 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.5 |
0.9 |
GO:1903243 |
negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.5 |
3.3 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.5 |
0.9 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.5 |
0.9 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.5 |
1.9 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.5 |
7.4 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.5 |
8.3 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.5 |
4.6 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.5 |
1.8 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.5 |
1.4 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.5 |
1.4 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.5 |
1.4 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.5 |
4.1 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.5 |
0.9 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.5 |
4.1 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.4 |
0.9 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.4 |
9.0 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.4 |
12.0 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.4 |
0.4 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.4 |
3.6 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.4 |
0.4 |
GO:2000277 |
positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
| 0.4 |
0.4 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.4 |
1.3 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.4 |
1.3 |
GO:0001907 |
killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.4 |
1.7 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.4 |
0.9 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.4 |
1.7 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.4 |
0.9 |
GO:2000832 |
protein-chromophore linkage(GO:0018298) negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.4 |
2.5 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.4 |
1.6 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.4 |
1.6 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.4 |
0.8 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.4 |
0.4 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.4 |
0.4 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.4 |
2.0 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 0.4 |
4.0 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.4 |
2.0 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.4 |
0.8 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.4 |
2.0 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.4 |
2.0 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.4 |
0.4 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.4 |
1.6 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.4 |
0.8 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) positive regulation of transforming growth factor beta3 production(GO:0032916) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.4 |
4.3 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.4 |
3.5 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.4 |
0.8 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.4 |
0.8 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.4 |
1.1 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.4 |
0.4 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.4 |
1.5 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.4 |
21.8 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.4 |
1.1 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.4 |
7.8 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.4 |
0.4 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.4 |
0.7 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.4 |
1.1 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.4 |
1.8 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.4 |
1.5 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.4 |
4.0 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.4 |
2.9 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.4 |
1.1 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.4 |
1.1 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.4 |
2.5 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.4 |
1.1 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.4 |
0.4 |
GO:0031498 |
chromatin disassembly(GO:0031498) |
| 0.4 |
1.4 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.3 |
1.4 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.3 |
3.4 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.3 |
1.0 |
GO:0046032 |
ADP catabolic process(GO:0046032) |
| 0.3 |
0.7 |
GO:0071428 |
rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
| 0.3 |
2.0 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.3 |
2.7 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.3 |
1.7 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.3 |
1.7 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.3 |
2.3 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.3 |
1.7 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.3 |
0.3 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.3 |
2.0 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.3 |
0.7 |
GO:0016241 |
regulation of macroautophagy(GO:0016241) |
| 0.3 |
2.0 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.3 |
3.0 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.3 |
0.7 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.3 |
0.7 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.3 |
1.3 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.3 |
0.7 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.3 |
1.6 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.3 |
9.1 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.3 |
0.6 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.3 |
0.6 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.3 |
2.6 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.3 |
2.2 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.3 |
1.9 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.3 |
2.8 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.3 |
3.8 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.3 |
0.9 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.3 |
3.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.3 |
1.3 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.3 |
3.4 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.3 |
1.9 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.3 |
2.5 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.3 |
1.6 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.3 |
0.9 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.3 |
0.9 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.3 |
1.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.3 |
3.1 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.3 |
0.9 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 |
0.6 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.3 |
1.5 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.3 |
1.2 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.3 |
1.2 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
| 0.3 |
2.1 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.3 |
0.3 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.3 |
7.4 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.3 |
12.2 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.3 |
0.6 |
GO:2000152 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) regulation of ubiquitin-specific protease activity(GO:2000152) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.3 |
0.9 |
GO:1904995 |
negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.3 |
0.9 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 |
4.1 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.3 |
0.9 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.3 |
0.9 |
GO:0046544 |
development of secondary male sexual characteristics(GO:0046544) |
| 0.3 |
5.0 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.3 |
0.3 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.3 |
0.9 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.3 |
0.6 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.3 |
1.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.3 |
0.6 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.3 |
0.6 |
GO:0002865 |
negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.3 |
1.1 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.3 |
1.7 |
GO:1900118 |
negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.3 |
4.2 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.3 |
2.0 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.3 |
2.5 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.3 |
6.5 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.3 |
0.8 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.3 |
8.4 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.3 |
0.3 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.3 |
0.8 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
| 0.3 |
1.4 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.3 |
0.3 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.3 |
0.8 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.3 |
1.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.3 |
3.3 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.3 |
2.7 |
GO:1903333 |
negative regulation of protein folding(GO:1903333) |
| 0.3 |
1.6 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.3 |
0.8 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.3 |
0.8 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.3 |
4.9 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.3 |
0.3 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.3 |
2.2 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.3 |
0.3 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.3 |
0.3 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.3 |
2.4 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.3 |
1.6 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.3 |
1.3 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.3 |
1.6 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.3 |
3.7 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.3 |
1.1 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.3 |
0.8 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.3 |
0.8 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.3 |
1.6 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.3 |
1.3 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.3 |
1.6 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 |
0.8 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.3 |
0.8 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.3 |
0.5 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 |
4.6 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.3 |
0.5 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.3 |
4.5 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.3 |
0.8 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.3 |
1.0 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.2 |
1.0 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.2 |
0.7 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.2 |
0.2 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.2 |
1.2 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.2 |
1.0 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.2 |
1.0 |
GO:0052490 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.2 |
1.0 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.2 |
1.0 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.2 |
3.9 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.2 |
1.0 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.2 |
0.2 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.2 |
0.7 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.2 |
0.5 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.2 |
1.4 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.2 |
2.1 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.2 |
0.7 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 |
1.0 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.2 |
1.7 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.2 |
3.3 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.2 |
0.7 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.2 |
2.1 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 |
2.8 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
0.9 |
GO:0042522 |
regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) |
| 0.2 |
0.7 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.2 |
0.7 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.2 |
0.9 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 |
0.9 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 |
1.1 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.2 |
0.2 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.2 |
0.7 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 |
0.5 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 |
1.3 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.2 |
0.4 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
1.1 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.2 |
0.4 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.2 |
1.8 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.2 |
1.1 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.2 |
7.0 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.2 |
2.0 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.2 |
0.4 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.2 |
4.8 |
GO:0009206 |
purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
| 0.2 |
0.2 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 |
3.3 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.2 |
1.3 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.2 |
0.6 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 |
4.3 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.2 |
0.2 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.2 |
0.6 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.2 |
0.9 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.2 |
1.3 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.2 |
1.1 |
GO:0019400 |
glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
| 0.2 |
1.9 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.2 |
0.6 |
GO:0097274 |
ductus arteriosus closure(GO:0097070) urea homeostasis(GO:0097274) |
| 0.2 |
2.9 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.2 |
0.4 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.2 |
1.0 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 0.2 |
0.4 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.2 |
0.2 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.2 |
0.6 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.2 |
5.2 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.2 |
0.4 |
GO:0009189 |
deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.2 |
1.2 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.2 |
4.1 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 |
0.8 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.2 |
0.4 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.2 |
1.2 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.2 |
0.8 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.2 |
1.6 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.2 |
1.4 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.2 |
1.4 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.2 |
1.4 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.2 |
0.8 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.2 |
1.2 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 |
1.8 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.2 |
0.8 |
GO:0003356 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.2 |
2.6 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.2 |
0.6 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.2 |
0.2 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.2 |
0.2 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.2 |
0.6 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
| 0.2 |
0.8 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.2 |
0.6 |
GO:0006901 |
vesicle coating(GO:0006901) |
| 0.2 |
0.8 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 |
0.6 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.2 |
5.8 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.2 |
0.4 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.2 |
1.7 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.2 |
0.6 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
1.5 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 |
0.4 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.2 |
0.4 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.2 |
0.4 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.2 |
0.6 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.2 |
0.4 |
GO:0046502 |
uroporphyrinogen III metabolic process(GO:0046502) |
| 0.2 |
1.1 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.2 |
0.8 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.2 |
1.1 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 0.2 |
0.9 |
GO:0003214 |
cardiac left ventricle morphogenesis(GO:0003214) |
| 0.2 |
1.5 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 |
0.4 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.2 |
0.7 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.2 |
0.4 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.2 |
0.7 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.2 |
0.9 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 |
1.8 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.2 |
2.5 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.2 |
2.9 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.2 |
2.0 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.2 |
1.6 |
GO:0034311 |
diol metabolic process(GO:0034311) |
| 0.2 |
0.7 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 |
1.2 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.2 |
0.7 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 |
0.9 |
GO:0044828 |
negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 |
1.4 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.2 |
0.5 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.2 |
0.3 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.2 |
1.4 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 |
0.7 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.2 |
2.1 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 |
0.3 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.2 |
0.5 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.2 |
4.1 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.2 |
0.3 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.2 |
12.2 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.2 |
3.3 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.2 |
0.3 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.2 |
0.7 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.2 |
1.4 |
GO:0060088 |
auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
| 0.2 |
0.5 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.2 |
1.3 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.2 |
6.6 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.2 |
3.2 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.2 |
0.8 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 |
0.8 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.2 |
0.7 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.2 |
0.5 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 |
0.8 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.2 |
0.3 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.2 |
0.6 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 |
0.8 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.2 |
2.4 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 |
0.8 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.2 |
0.6 |
GO:0032462 |
regulation of protein homooligomerization(GO:0032462) |
| 0.2 |
0.5 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
3.2 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.2 |
0.3 |
GO:0001828 |
inner cell mass cell differentiation(GO:0001826) inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 |
0.3 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 |
0.9 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.2 |
3.6 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.2 |
0.5 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 |
1.2 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.2 |
0.6 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.2 |
2.3 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.2 |
0.5 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.2 |
1.9 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.2 |
0.9 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.2 |
1.5 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.2 |
0.3 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.2 |
3.2 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.2 |
0.6 |
GO:0070827 |
chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 0.2 |
0.6 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.2 |
0.6 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.2 |
0.8 |
GO:0070171 |
negative regulation of tooth mineralization(GO:0070171) |
| 0.2 |
0.5 |
GO:0033574 |
response to testosterone(GO:0033574) |
| 0.2 |
0.5 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.1 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
2.4 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
4.7 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
1.0 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
0.1 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.1 |
0.1 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 |
4.4 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.3 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 |
0.9 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.1 |
0.3 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 |
1.5 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
1.5 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.1 |
1.3 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
0.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
1.7 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
1.0 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
1.6 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
4.3 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
13.0 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.1 |
0.4 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.1 |
0.7 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.4 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
1.4 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
2.2 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.1 |
17.1 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.1 |
1.8 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.1 |
0.4 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.1 |
0.6 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
1.0 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 |
0.7 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.1 |
0.3 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.1 |
0.8 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.1 |
2.0 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
1.3 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
0.5 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.1 |
0.7 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.1 |
0.3 |
GO:1900453 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of neurotrophin production(GO:0032899) negative regulation of long term synaptic depression(GO:1900453) |
| 0.1 |
0.3 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 |
0.4 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.1 |
0.7 |
GO:0002883 |
regulation of hypersensitivity(GO:0002883) |
| 0.1 |
1.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
1.7 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
1.7 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 |
1.3 |
GO:0010642 |
negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.1 |
0.1 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 |
0.4 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 |
0.1 |
GO:0021612 |
facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) |
| 0.1 |
0.6 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.1 |
0.4 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.1 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 |
0.4 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 |
0.9 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.1 |
8.9 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 |
0.6 |
GO:1902165 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.1 |
0.9 |
GO:1903311 |
regulation of mRNA metabolic process(GO:1903311) |
| 0.1 |
1.1 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.1 |
1.0 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.1 |
0.4 |
GO:0090237 |
regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.1 |
1.0 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.1 |
0.3 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.1 |
2.3 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.1 |
0.4 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.1 |
0.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
1.9 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.1 |
0.6 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.1 |
5.9 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.2 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.1 |
0.6 |
GO:0090305 |
nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
| 0.1 |
0.4 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
0.5 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 |
0.6 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.1 |
0.8 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 |
1.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 |
0.6 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.7 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
0.3 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.5 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.1 |
0.2 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.1 |
1.5 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.1 |
0.2 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 |
1.4 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
0.5 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 |
0.5 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.9 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
0.2 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.1 |
1.8 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.1 |
0.7 |
GO:0033240 |
positive regulation of cellular amine metabolic process(GO:0033240) |
| 0.1 |
0.2 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.1 |
0.9 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.1 |
0.2 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
2.9 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.1 |
0.2 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 |
1.5 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.9 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 |
0.3 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.3 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.1 |
0.4 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 |
0.6 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.7 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.1 |
0.4 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.1 |
1.3 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.1 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.1 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.1 |
0.8 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 |
1.0 |
GO:0000077 |
DNA damage checkpoint(GO:0000077) DNA integrity checkpoint(GO:0031570) |
| 0.1 |
1.8 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.3 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
1.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
0.4 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.5 |
GO:0010454 |
negative regulation of cell fate commitment(GO:0010454) |
| 0.1 |
0.6 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
0.3 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.1 |
0.3 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.2 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.5 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
0.8 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.2 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.1 |
0.4 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.1 |
0.2 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.1 |
0.3 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
1.1 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.1 |
1.2 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.1 |
0.4 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 |
0.3 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.1 |
0.3 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.4 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
0.3 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.6 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.1 |
0.5 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.4 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
1.2 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.1 |
0.5 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
0.1 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 |
2.9 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
2.1 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.1 |
0.3 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.1 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 |
7.1 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.1 |
0.3 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.1 |
2.4 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
0.6 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.3 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.2 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.1 |
0.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.2 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.1 |
0.4 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.1 |
0.6 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.1 |
0.5 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) mitochondrial protein processing(GO:0034982) |
| 0.1 |
0.7 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.9 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
0.3 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 |
0.4 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.4 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.1 |
0.6 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.1 |
0.5 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.1 |
0.4 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
1.5 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 |
0.5 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.2 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 |
1.5 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
0.6 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.5 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.1 |
0.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.2 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 |
0.2 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
0.6 |
GO:0014742 |
positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.1 |
0.7 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.5 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 |
1.2 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.4 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.1 |
1.3 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.5 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.5 |
GO:1904851 |
positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.1 |
0.4 |
GO:0046037 |
GMP biosynthetic process(GO:0006177) GMP metabolic process(GO:0046037) |
| 0.1 |
1.1 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
0.3 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
1.5 |
GO:0040023 |
establishment of nucleus localization(GO:0040023) |
| 0.1 |
0.4 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.1 |
0.8 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.1 |
0.7 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.1 |
0.2 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
0.5 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.1 |
1.3 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
0.1 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 |
0.4 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.1 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.3 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 |
1.0 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.1 |
0.6 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.2 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
1.4 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.1 |
0.2 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 |
4.0 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
0.1 |
GO:0071639 |
positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.1 |
0.8 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 |
0.1 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.1 |
0.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
3.1 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.1 |
0.8 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.3 |
GO:0045852 |
lysosomal lumen pH elevation(GO:0035752) pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.1 |
0.3 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.1 |
0.3 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
0.3 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 |
0.3 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) trophectodermal cell proliferation(GO:0001834) |
| 0.1 |
0.3 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.9 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.3 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
2.7 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.6 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.1 |
0.3 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
1.1 |
GO:0042491 |
auditory receptor cell differentiation(GO:0042491) |
| 0.1 |
0.1 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
0.5 |
GO:2000727 |
positive regulation of cardiocyte differentiation(GO:1905209) positive regulation of cardiac muscle cell differentiation(GO:2000727) |
| 0.1 |
0.5 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.1 |
0.5 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.3 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
0.1 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 |
0.3 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.2 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 |
0.1 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.1 |
0.6 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.1 |
1.0 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.1 |
0.3 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.1 |
0.4 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
0.5 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 |
0.3 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.7 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.1 |
0.2 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 |
0.2 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
1.1 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.2 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.1 |
0.2 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
0.1 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
0.2 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.1 |
0.7 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.3 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.1 |
0.6 |
GO:0007595 |
lactation(GO:0007595) |
| 0.1 |
0.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.3 |
GO:0009136 |
ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.1 |
0.3 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.1 |
0.3 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.3 |
GO:0045061 |
positive thymic T cell selection(GO:0045059) thymic T cell selection(GO:0045061) |
| 0.1 |
0.3 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.1 |
0.1 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 |
0.3 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
0.8 |
GO:0071384 |
cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
| 0.1 |
0.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.3 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 |
0.2 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
0.2 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.1 |
0.3 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.1 |
0.7 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.1 |
0.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.2 |
GO:0046134 |
pyrimidine nucleoside biosynthetic process(GO:0046134) |
| 0.1 |
0.4 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.1 |
0.4 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.1 |
0.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
0.2 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.1 |
0.2 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 |
0.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.3 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.1 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.4 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.2 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.0 |
0.8 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.1 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
0.5 |
GO:2000741 |
mesenchymal stem cell differentiation(GO:0072497) regulation of mesenchymal stem cell differentiation(GO:2000739) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 |
0.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 |
0.5 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.0 |
0.5 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.0 |
0.4 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.1 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.0 |
0.2 |
GO:0044819 |
mitotic G1 DNA damage checkpoint(GO:0031571) mitotic G1/S transition checkpoint(GO:0044819) |
| 0.0 |
0.2 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.0 |
0.7 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.0 |
0.1 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.0 |
0.5 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.0 |
1.1 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 |
0.3 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.0 |
0.2 |
GO:0072537 |
fibroblast activation(GO:0072537) |
| 0.0 |
0.8 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.3 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.0 |
0.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.3 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.0 |
0.5 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.0 |
1.0 |
GO:0007346 |
regulation of mitotic cell cycle(GO:0007346) |
| 0.0 |
0.1 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.0 |
0.2 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 |
1.2 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.2 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
0.4 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.0 |
0.2 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.0 |
0.2 |
GO:1904526 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
| 0.0 |
0.2 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.3 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.0 |
0.3 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.0 |
0.2 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.0 |
0.3 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.3 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.0 |
0.4 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 |
1.7 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.0 |
1.8 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.1 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.0 |
0.1 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.0 |
0.1 |
GO:2001197 |
positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.0 |
1.4 |
GO:0045010 |
actin nucleation(GO:0045010) |
| 0.0 |
0.3 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.0 |
1.0 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 |
0.1 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.0 |
0.3 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.4 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.1 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.0 |
0.1 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.1 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.2 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.3 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.2 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.2 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
| 0.0 |
0.3 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.0 |
0.1 |
GO:0045954 |
positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.0 |
0.1 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.0 |
0.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.3 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.0 |
0.5 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.2 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.2 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.0 |
0.4 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.3 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
| 0.0 |
0.7 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.4 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.0 |
0.3 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.0 |
0.8 |
GO:0010717 |
regulation of epithelial to mesenchymal transition(GO:0010717) |
| 0.0 |
0.0 |
GO:0006403 |
RNA localization(GO:0006403) |
| 0.0 |
0.3 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.0 |
0.1 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.0 |
0.3 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.0 |
0.2 |
GO:0006584 |
catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.0 |
0.2 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.0 |
0.2 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.0 |
0.1 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.1 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.0 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 |
0.1 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.0 |
0.1 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.0 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.0 |
0.0 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.0 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.0 |
0.1 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.0 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.0 |
0.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.1 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.0 |
0.1 |
GO:0031664 |
regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
| 0.0 |
0.2 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.3 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.0 |
0.2 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.0 |
0.1 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.1 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.2 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.0 |
0.2 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
0.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.3 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 |
0.0 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.0 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.1 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 |
0.1 |
GO:0016458 |
gene silencing(GO:0016458) |
| 0.0 |
0.0 |
GO:0043243 |
positive regulation of protein complex disassembly(GO:0043243) |
| 0.0 |
0.2 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.0 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 |
0.1 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 |
0.3 |
GO:0007127 |
meiosis I(GO:0007127) |
| 0.0 |
0.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.5 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.0 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
